```html

Yellow Plaques on the Eyelids (Xanthelasma)

What is Yellow plaques on the eyelids (xanthelasma)?

Xanthelasma (pronounced zan‑the‑LAT‑muh) are soft, yellow‑orange plaques that appear on the medial (inner) portions of the upper and lower eyelids. They are composed of collections of lipid‑laden foam cells (a type of macrophage) in the dermis. Although the lesions are benign and usually painless, they can be a visible sign of underlying lipid metabolism disorders and may cause cosmetic concern.

The condition is more common in adults between 40 and 60 years of age, but it can occur at any age, including in children with inherited lipid disorders. Xanthelasma occurs slightly more often in women than men and is seen more frequently in people of Asian, Middle‑Eastern, or Mediterranean descent.<sup>1</sup>

Common Causes

Yellow plaques on the eyelids are usually a manifestation of an underlying systemic condition that alters lipid handling. The most frequent causes include:

• Primary hyperlipidemia: Elevated low‑density lipoprotein (LDL) or total cholesterol, often due to familial hypercholesterolemia.
• Secondary hyperlipidemia: High cholesterol related to diabetes mellitus, hypothyroidism, nephrotic syndrome, or chronic liver disease.
• Obesity: Excess adipose tissue can increase circulating triglycerides and LDL.
• Metabolic syndrome: A cluster of hypertension, insulin resistance, central obesity, and dyslipidemia.
• Familial dysbetalipoproteinemia (type III hyperlipoproteinemia): Leads to accumulation of chylomicron remnants and very‑low‑density lipoproteins.
• Medication‑induced lipid changes: Long‑term corticosteroids, retinoids, or certain antiretrovirals can raise serum lipids.
• Genetic disorders of lipid metabolism: Including sitosterolemia or LCAT deficiency.
• Age‑related changes: Lipid metabolism naturally shifts with age, making older adults more prone.
• Hormonal influences: Post‑menopausal estrogen decline may worsen lipid profiles.
• Idiopathic: In up to 20 % of cases, no abnormal lipid levels are identified; the plaques are considered isolated.

Associated Symptoms

While xanthelasma itself is painless, it can coexist with other signs that hint at systemic disease:

• Accompanying xanthomas on elbows, knees, or tendons.
• Yellowish deposits on the hands (palmar xanthomas) or around the nails (xanthonychia).
• Fatigue, weakness, or unexplained weight loss (possible diabetes or thyroid disease).
• Chest pain or shortness of breath (suggesting coronary artery disease linked to high cholesterol).
• Dry skin, hair loss, or cold intolerance (hypothyroidism).
• Swelling of the feet or abdomen (nephrotic syndrome).

When to See a Doctor

Although xanthelasma is benign, medical evaluation is important because it may be the visible tip of a systemic problem. Seek care promptly if you notice:

• Rapid growth or sudden appearance of new plaques.
• Lesions that become itchy, painful, bleed, or develop ulceration.
• Any visual changes, such as blurred vision or eye discomfort.
• History of high cholesterol, heart disease, diabetes, or thyroid disorders.
• Family history of early‑onset heart attacks or familial hypercholesterolemia.

Early evaluation allows for lipid testing, cardiovascular risk assessment, and discussion of treatment options.

Diagnosis

Diagnosis is mainly clinical, but a systematic work‑up helps uncover underlying disease.

1. Physical examination

• Inspection of eyelids for size, number, and distribution of plaques.
• Full skin exam to look for other xanthomas.
• Palpation to confirm the soft, non‑tender nature of the lesions.

2. Laboratory tests

• Lipid profile: Total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Glucose testing: Fasting glucose or HbA1c to screen for diabetes.
• Thyroid function: TSH and free T4 to rule out hypothyroidism.
• Liver and kidney panels: To identify secondary causes such as nephrotic syndrome.
• Optional genetic testing for familial hypercholesterolemia if lipid levels are markedly elevated and family history is strong.

3. Imaging (if indicated)

• Carotid duplex ultrasonography or coronary calcium scoring may be recommended for patients with high cardiovascular risk.

4. Histopathology (rare)

Only performed when the diagnosis is uncertain. A skin biopsy shows lipid‑laden macrophages within the dermis.

Treatment Options

Management targets two goals: (1) cosmetic removal of the plaques, and (2) correction of any underlying lipid disorder to prevent recurrence and reduce cardiovascular risk.

1. Lifestyle & medical management of lipids

• Dietary changes: Adopt a Mediterranean‑style diet rich in fruits, vegetables, whole grains, nuts, and oily fish; limit saturated fat, trans fat, and added sugars.
• Physical activity: At least 150 minutes of moderate aerobic exercise per week.
• Weight control: Achieve and maintain a BMI < 25 kg/m² when possible.
• Smoking cessation: Smoking accelerates atherosclerosis and worsens lipid profiles.
• Pharmacotherapy: Statins are first‑line for LDL reduction; ezetimibe, PCSK9 inhibitors, or fibrates may be added based on the lipid pattern and tolerance.<sup>2</sup>

2. Cosmetic removal of lesions

Choice of procedure depends on size, location, and patient preference.

• Laser therapy: CO₂ or Nd:YAG lasers effectively vaporize the plaque with minimal scarring. Multiple sessions may be needed.
• Radiofrequency or electrosurgical ablation: Uses heat to destroy the lesion; typically performed in an office setting.
• Surgical excision: Small lesions can be cut out with a scalpel; sutures are usually fine and hidden.
• Chemical peels (trichloroacetic acid): Occasionally used for very superficial plaques, though risk of pigment changes exists.
• Cryotherapy: Freezing with liquid nitrogen; less commonly used due to risk of skin discoloration.

All procedures should be performed by an ophthalmic plastic surgeon or dermatologist experienced with peri‑ocular tissue to avoid damage to the eye.

3. Home and supportive care

• Apply a gentle moisturizer after any procedure to support healing.
• Use broad‑spectrum sunscreen on the eyelids (SPF 30 or higher) to prevent post‑procedure hyperpigmentation.
• Avoid harsh rubbing of the eyes, which can irritate the lesions.

Prevention Tips

While you cannot guarantee that xanthelasma will never develop, reducing the risk factors lowers both the chance of recurrence and the chance of serious cardiovascular disease.

• Maintain optimal lipid levels: Aim for LDL‑C < 100 mg/dL (or <70 mg/dL if you have established heart disease).
• Follow a heart‑healthy diet: Emphasize soluble fiber (oats, legumes) and omega‑3 fatty acids.
• Exercise regularly: Improves HDL‑C and helps lower triglycerides.
• Control blood sugar: Keep HbA1c below 7 % if diabetic.
• Screen for thyroid disease: Treat hypothyroidism promptly.
• Limit alcohol intake: Excessive alcohol can raise triglycerides.
• Regular health check‑ups: Lipid panels every 4‑6 years for adults; sooner if you have risk factors.
• Eye protection: Sunglasses with UV protection reduce oxidative stress on peri‑ocular skin.

Emergency Warning Signs

---

References:

1. Mayo Clinic. “Xanthelasma – Symptoms and causes.” https://www.mayoclinic.org. Accessed May 2026.
2. National Cholesterol Education Program (NCEP) Adult Treatment Panel III. “Guidelines for the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.” 2002; updates 2018. https://www.nhlbi.nih.gov.
3. American College of Cardiology/American Heart Association. “2019 Guideline on the Primary Prevention of Cardiovascular Disease.” Circulation.
4. Cleveland Clinic. “Xanthelasma – What causes these yellow eyelid patches?” https://my.clevelandclinic.org. Accessed May 2026.
5. World Health Organization. “Noncommunicable diseases: cardiovascular diseases (CVDs).” https://www.who.int.

```